Ibogamine

Ibogamine
Clinical data
ATC code	none;
Identifiers
	IUPAC name[show]
CAS Number	481-87-8 ;
PubChem CID	100217;
ChemSpider	90568 ;
ChEBI	CHEBI:5853 ;
Chemical and physical data
Formula	C19H24N2
Molar mass	280.41 g/mol g·mol−1
	InChI[show]
(what is this?) (verify)

Ibogamine is an alkaloid found in Tabernanthe iboga. Basic research related to how addiction affects the brain has used this chemical. Ibogamine persistently reduced the self-administration of cocaine and morphine in rats.. The same study found that Ibogamine (40mg/kg) and Coronaridine (40mg/kg) did not produce “any tremor effects in rats that differ significantly from saline control”. While the related alkaloids Ibogaine(20-40 mg/kg), harmaline (10-40 mg/kg) and desethylcoronaridine (10-40 mg/kg) were “obviously tremorgenic”.

References

^ Bartlett, M. F.; Dickel, D. F.; Taylor, W. I. (1958). “The Alkaloids of Tabernanthe iboga. Part IV.1 The Structures of Ibogamine, Ibogaine, Tabernanthine and Voacangine – Journal of the American Chemical Society (ACS Publications)”. Journal of the American Chemical Society. 80 (1): 126–136. doi:10.1021/ja01534a036.
^ Kuehne, Martin E.; Reider, Paul J. (1985). “A synthesis of ibogamine – The Journal of Organic Chemistry (ACS Publications)”. The Journal of Organic Chemistry. 50 (9): 1464–1467. doi:10.1021/jo00209a020.
^ Levi MS, Borne RF (October 2002). “A review of chemical agents in the pharmacotherapy of addiction”. Curr. Med. Chem. 9 (20): 1807–18. doi:10.2174/0929867023368980. PMID 12369879.
^ Jump up to:^a ^b Glick SD, Kuehne ME, Raucci J, Wilson TE, Larson D, Keller RW Jr, Carlson JN (September 1994). “Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum”. Brain Res. 657 (1–2): 14–22. doi:10.1016/0006-8993(94)90948-2. PMID 7820611.

From Wikipedia, the free encyclopedia

[urlThe_Alkaloids_of_Tabernanthe_iboga._Part_IV.1_The_Structures_of_Ibogamine,_Ibogaine,_Tabernanthine_and_Voacangine_-_Journal_of_the_American_Chemical_Society_(ACS_Publications)-1] Bartlett, M. F.; Dickel, D. F.; Taylor, W. I. (1958). “The Alkaloids of Tabernanthe iboga. Part IV.1 The Structures of Ibogamine, Ibogaine, Tabernanthine and Voacangine – Journal of the American Chemical Society (ACS Publications)”. Journal of the American Chemical Society. 80 (1): 126–136. doi:10.1021/ja01534a036.

[urlA_synthesis_of_ibogamine_-_The_Journal_of_Organic_Chemistry_(ACS_Publications)-2] Kuehne, Martin E.; Reider, Paul J. (1985). “A synthesis of ibogamine – The Journal of Organic Chemistry (ACS Publications)”. The Journal of Organic Chemistry. 50 (9): 1464–1467. doi:10.1021/jo00209a020.

[3] Levi MS, Borne RF (October 2002). “A review of chemical agents in the pharmacotherapy of addiction”. Curr. Med. Chem. 9 (20): 1807–18. doi:10.2174/0929867023368980. PMID 12369879.

[ref4-4] Jump up to:^a ^b Glick SD, Kuehne ME, Raucci J, Wilson TE, Larson D, Keller RW Jr, Carlson JN (September 1994). “Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum”. Brain Res. 657 (1–2): 14–22. doi:10.1016/0006-8993(94)90948-2. PMID 7820611.

Ibogaine – Ibogamine

Ibogamine

See also

References

Clinical data


ATC code	none
Identifiers
IUPAC name [show]
CAS Number	481-87-8
PubChem CID	100217
ChemSpider	90568
ChEBI	CHEBI:5853
Chemical and physical data
Formula	C₁₉H₂₄N₂
Molar mass	280.41 g/mol g·mol⁻¹
InChI [show]
(what is this?) (verify)

Ibogaine – Ibogamine

Ibogamine

See also

References

Related Posts